Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARMSTRONG WORLD INDUSTRIES INCAWI · Entity 3696 | Director | November 29, 2019 | December 02, 2019 |
| SAFEGUARD SCIENTIFICS INCSFE · Entity 9612 | Director | April 15, 2020 | April 16, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARMSTRONG WORLD INDUSTRIES INC
Report date November 29, 2019 · Filed December 02, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,497 |
Reported balance
After 2019-11-29 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2019-11-29 · Gift · Disposed 2,000 · Balance 23,497 F1: Includes vested and unvested units as well as units not yet acquirable by the Director. Under the terms of the 2008 Directors Stock Unit Plan, as amended (the "2008 Plan"), vested units under the 2008 Plan are not acquirable by the Director until (i) for those restricted stock units granted prior to June 2011, six (6) months following the termination of service on the Issuer's Board of Directors, and, (ii) for those units granted during and after June 2011, at the time of termination of service on the Issuer's Board of Directors. Under the terms of the 2016 Directors Stock Unit Plan, as amended (the "2016 Plan"), vested units under the 2016 Plan are not acquirable by the Director until, at the election of the Director: (i) the vesting of the units at the one-year anniversary of the grant or (ii) the time of the Director's termination of service. The shares comprising the bona fide gift are from vested units. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes vested and unvested units as well as units not yet acquirable by the Director. Under the terms of the 2008 Directors Stock Unit Plan, as amended (the "2008 Plan"), vested units under the 2008 Plan are not acquirable by the Director until (i) for those restricted stock units granted prior to June 2011, six (6) months following the termination of service on the Issuer's Board of Directors, and, (ii) for those units granted during and after June 2011, at the time of termination of service on the Issuer's Board of Directors. Under the terms of the 2016 Directors Stock Unit Plan, as amended (the "2016 Plan"), vested units under the 2016 Plan are not acquirable by the Director until, at the election of the Director: (i) the vesting of the units at the one-year anniversary of the grant or (ii) the time of the Director's termination of service. The shares comprising the bona fide gift are from vested units.
SAFEGUARD SCIENTIFICS INC
Report date April 15, 2020 · Filed April 16, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 28,109 |
Reported balance
After 2020-04-15 transaction · row 1
1 source rowRow 1 · 2020-04-15 · Grant · Acquired 2,843 · Balance 28,109 F1: The securities reported in Table I were awarded to the reporting person in lieu of quarterly fees for service on the Issuer's Board of Directors, which fees are paid in arrears following the end of the quarter |
Filing footnotes · ownership attribution and instrument terms
F1: The securities reported in Table I were awarded to the reporting person in lieu of quarterly fees for service on the Issuer's Board of Directors, which fees are paid in arrears following the end of the quarter
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
PENNSYLVANIA REAL ESTATE INVESTMENT TRUST
Report date April 01, 2024 · Filed April 03, 2024
Section 16 reporting ended · disclosed 2024-04-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Shares of Beneficial Interest, par value $1.00 per shareSEC Table I · non-derivative | IndirectSee Footnote | 0 |
Reported balance
After 2024-04-01 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2024-04-01 · Other · Disposed 12,816 · Balance 0 F1: On December 10, 2023, Pennsylvania Real Estate Investment Trust (the "Issuer") and certain of its direct and indirect affiliates (collectively, with the Issuer, the "Debtors"), filed voluntary petitions under chapter 11 of the Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") to pursue a joint prepackaged chapter 11 plan as contemplated by the Restructuring Support Agreement, dated December 7, 2023. On January 23, 2024, the Bankruptcy Court entered an order confirming the Modified Joint Prepackaged Chapter 11 Plan of Reorganization of Pennsylvania Real Estate Investment Trust and Its Debtor-Affiliates (the "Plan") of the Debtors. On April 1, 2024 (the "Effective Date"), the Plan became effective pursuant to its terms and the Debtors emerged from bankruptcy. F2: On the Effective Date, all classes of preferred and common securities issued by the Company, namely the Company's prior Shares of Beneficial Interest, par value $1.00 per share (the "Common Shares"), including any remaining outstanding restricted share units, performance-based restricted share units, options, warrants, rights, or other securities or agreements to acquire such Common Shares, Series B Preferred Shares, par value $0.01 per share, Series C Preferred Shares, par value $0.01 per share, and Series D Preferred Shares, par value $0.01 per share, were automatically cancelled and extinguished as of the Effective Date. The limited partnership units in the operating partnership of PREIT Associates, L.P. not owned by the Issuer were also cancelled on the Effective Date. F3: As of the Effective Date, holders of Common Shares received, or will receive shortly after the Effective Date, their pro rata share of a gift of $10 million in cash. Holders of Common Shares are to receive $0.55624252 per share. F4: 12,816 Shares held indirectly in a revocable trust. |
Filing footnotes · ownership attribution and instrument terms
F1: On December 10, 2023, Pennsylvania Real Estate Investment Trust (the "Issuer") and certain of its direct and indirect affiliates (collectively, with the Issuer, the "Debtors"), filed voluntary petitions under chapter 11 of the Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") to pursue a joint prepackaged chapter 11 plan as contemplated by the Restructuring Support Agreement, dated December 7, 2023. On January 23, 2024, the Bankruptcy Court entered an order confirming the Modified Joint Prepackaged Chapter 11 Plan of Reorganization of Pennsylvania Real Estate Investment Trust and Its Debtor-Affiliates (the "Plan") of the Debtors. On April 1, 2024 (the "Effective Date"), the Plan became effective pursuant to its terms and the Debtors emerged from bankruptcy.
F2: On the Effective Date, all classes of preferred and common securities issued by the Company, namely the Company's prior Shares of Beneficial Interest, par value $1.00 per share (the "Common Shares"), including any remaining outstanding restricted share units, performance-based restricted share units, options, warrants, rights, or other securities or agreements to acquire such Common Shares, Series B Preferred Shares, par value $0.01 per share, Series C Preferred Shares, par value $0.01 per share, and Series D Preferred Shares, par value $0.01 per share, were automatically cancelled and extinguished as of the Effective Date. The limited partnership units in the operating partnership of PREIT Associates, L.P. not owned by the Issuer were also cancelled on the Effective Date.
F3: As of the Effective Date, holders of Common Shares received, or will receive shortly after the Effective Date, their pro rata share of a gift of $10 million in cash. Holders of Common Shares are to receive $0.55624252 per share.
F4: 12,816 Shares held indirectly in a revocable trust.
VONAGE HOLDINGS CORP
Report date July 21, 2022 · Filed July 21, 2022
Section 16 reporting ended · disclosed 2022-07-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2022-07-21 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2022-07-21 · Disposition to issuer · Disposed 215,181 · Balance 0 Row 2 · 2022-07-21 · Exercise / conversion · Acquired 10,000 · Balance 10,000 Row 3 · 2022-07-21 · Disposition to issuer · Disposed 10,000 · Balance 0 |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.28 · Expires 2022-10-01 | Direct | 0 |
Reported balance
After 2022-07-21 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-07-21 · Exercise / conversion · Disposed 10,000 · Balance 0 F1: The options vested over a four (4) year period, with 25% vesting on October 1, 2012 and the balance vesting in equal quarterly installments over the remaining three (3) year |
Filing footnotes · ownership attribution and instrument terms
F1: The options vested over a four (4) year period, with 25% vesting on October 1, 2012 and the balance vesting in equal quarterly installments over the remaining three (3) year
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2018 Filed Apr 3, 2018 18:53 UTC | VONAGE HOLDINGS CORP VG · Entity 125236 | GrantCommon Stock | 2,699 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-023325 · doc4.xml · nonDerivative · entry 1 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,201 Read SEC document |
| February 27, 2018 Filed Feb 28, 2018 18:10 UTC | VONAGE HOLDINGS CORP VG · Entity 125236 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $1.85 | $0.00 |
DisclosureSEC source: 0001209191-18-014654 · doc4.xml · derivative · entry 3 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,750 shares Expires 2018-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option, representing a right to purchase a total of 3,750 shares, vested in equal quarterly installments over a period of twelve months beginning March 1, 2008. Read SEC document |
| February 27, 2018 Filed Feb 28, 2018 18:10 UTC | VONAGE HOLDINGS CORP VG · Entity 125236 | Tax withholdingCommon Stock | 680 | $10.22 | $6,946.20 |
DisclosureSEC source: 0001209191-18-014654 · doc4.xml · nonDerivative · entry 2 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,502 Read SEC document |
| February 27, 2018 Filed Feb 28, 2018 18:10 UTC | VONAGE HOLDINGS CORP VG · Entity 125236 | Exercise / conversionCommon Stock | 3,750 | $1.85 | $6,937.50 |
DisclosureSEC source: 0001209191-18-014654 · doc4.xml · nonDerivative · entry 1 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,182 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 15, 2018 Filed Jan 16, 2018 16:56 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantDeferred Stock Units (Match) · Derivative | 563 | $0.00 | $0.00 |
DisclosureSEC source: 0000086115-18-000012 · wf-form4_151612174762228.xml · derivative · entry 2 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,012 Underlying: Common Stock · 563 shares Expires not disclosed F1 · derivative.exercise_price: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. F1 · derivative.exercise_date: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. F1 · derivative.expiration_date: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. Read SEC document |
| January 15, 2018 Filed Jan 16, 2018 16:56 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantDeferred Stock Units (Fee Deferral) · Derivative | 2,252 | $11.10 | $24,997.20 |
DisclosureSEC source: 0000086115-18-000012 · wf-form4_151612174762228.xml · derivative · entry 1 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,069 Underlying: Common Stock · 2,252 shares Expires not disclosed F1 · derivative.exercise_price: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. F1 · derivative.exercise_date: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. F1 · derivative.expiration_date: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. Read SEC document |
| January 01, 2018 Filed Jan 3, 2018 17:55 UTC | VONAGE HOLDINGS CORP VG · Entity 125236 | GrantCommon Stock | 2,826 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-001215 · doc4.xml · nonDerivative · entry 3 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,432 Read SEC document |
| December 28, 2017 Filed Jan 3, 2018 17:55 UTC | VONAGE HOLDINGS CORP VG · Entity 125236 | GiftCommon Stock | 8,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-001215 · doc4.xml · nonDerivative · entry 2 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,606 F2 · shares: Represents gifting of shares to The John and Charlene Roberts Family Foundation, Inc. Read SEC document |
| December 20, 2017 Filed Jan 3, 2018 17:55 UTC | VONAGE HOLDINGS CORP VG · Entity 125236 | GiftCommon Stock | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-001215 · doc4.xml · nonDerivative · entry 1 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,922 F1 · shares: Represents gifting of 4,000 shares to each of John Roberts Jr. and Alex Roberts, and 3,000 shares to each of Diane Roberts and Christopher Roberts, Reporting Person's adult children. Read SEC document |
| November 30, 2017 Filed Dec 4, 2017 15:53 UTC | PENNSYLVANIA REAL ESTATE INVESTMENT TRUST PEI · Entity 92323 | GrantShares of Beneficial Interest, par value $1.00 per share | 9,194 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001351595-17-000022 · primary_doc.xml · nonDerivative · entry 1 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,254 F1 · price: Grant of restricted shares for no consideration. Read SEC document |
| November 30, 2017 Filed Jan 17, 2018 17:00 UTC Amendment | PENNSYLVANIA REAL ESTATE INVESTMENT TRUST PEI · Entity 92323 | GrantShares of Beneficial Interest, par value $1.00 per share | 9,194 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001351595-18-000002 · primary_doc.xml · nonDerivative · entry 1 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,644 F1 · price: Grant of restricted shares for no consideration. F2 · balance_after: This number has been amended to reflect an additional 390 shares that the reporting person received as reinvested dividends that were not reported on the initial filing. Read SEC document |
| November 16, 2017 Filed Nov 20, 2017 17:59 UTC | VONAGE HOLDINGS CORP VG · Entity 125236 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0001209191-17-061855 · doc4.xml · derivative · entry 3 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,750 shares Expires 2017-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option, representing a right to purchase a total of 3,750 shares, vested in equal quarterly installments over a period of twelve months beginning December 1, 2007. Read SEC document |
| November 16, 2017 Filed Nov 20, 2017 17:59 UTC | VONAGE HOLDINGS CORP VG · Entity 125236 | Tax withholdingCommon Stock | 864 | $9.16 | $7,914.24 |
DisclosureSEC source: 0001209191-17-061855 · doc4.xml · nonDerivative · entry 2 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,922 Read SEC document |
| November 16, 2017 Filed Nov 20, 2017 17:59 UTC | VONAGE HOLDINGS CORP VG · Entity 125236 | Exercise / conversionCommon Stock | 3,750 | $2.11 | $7,912.50 |
DisclosureSEC source: 0001209191-17-061855 · doc4.xml · nonDerivative · entry 1 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,786 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 15, 2017 Filed Oct 16, 2017 18:59 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantDeferred Stock Units (Match) · Derivative | 442 | $0.00 | $0.00 |
DisclosureSEC source: 0000086115-17-000124 · wf-form4_150818032715678.xml · derivative · entry 2 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,449 Underlying: Common Stock · 442 shares Expires not disclosed F2 · derivative.exercise_price: The deferred stock units are payable in stock, on a one-for-one basis, and vest on the first anniversary of the grant date. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. F2 · derivative.exercise_date: The deferred stock units are payable in stock, on a one-for-one basis, and vest on the first anniversary of the grant date. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. F2 · derivative.expiration_date: The deferred stock units are payable in stock, on a one-for-one basis, and vest on the first anniversary of the grant date. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. Read SEC document |
| October 15, 2017 Filed Oct 16, 2017 18:59 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantDeferred Stock Units (Fee Deferral) · Derivative | 1,767 | $14.15 | $25,003.05 |
DisclosureSEC source: 0000086115-17-000124 · wf-form4_150818032715678.xml · derivative · entry 1 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,817 Underlying: Common Stock · 1,767 shares Expires not disclosed F1 · derivative.exercise_price: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. F1 · derivative.exercise_date: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. F1 · derivative.expiration_date: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. Read SEC document |
| October 01, 2017 Filed Oct 3, 2017 18:21 UTC | VONAGE HOLDINGS CORP VG · Entity 125236 | GrantCommon Stock | 3,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-055401 · doc4.xml · nonDerivative · entry 1 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,036 Read SEC document |
| August 14, 2017 Filed Jul 3, 2018 17:42 UTC | VONAGE HOLDINGS CORP VG · Entity 125236 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0001272830-18-000055 · wf-form4_153065414745408.xml · derivative · entry 4 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 3,750 shares Expires 2017-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option, representing a right to purchase a total of 3,750 shares, vested in equal quarterly installments over a period of twelve months beginning September 1, 2007. Read SEC document |
| August 14, 2017 Filed Jul 3, 2018 17:42 UTC | VONAGE HOLDINGS CORP VG · Entity 125236 | Tax withholdingCommon Stock | 968 | $8.18 | $7,918.24 |
DisclosureSEC source: 0001272830-18-000055 · wf-form4_153065414745408.xml · nonDerivative · entry 2 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,555 Read SEC document |
| August 14, 2017 Filed Jul 3, 2018 17:42 UTC | VONAGE HOLDINGS CORP VG · Entity 125236 | Exercise / conversionCommon Stock | 3,750 | $2.11 | $7,912.50 |
DisclosureSEC source: 0001272830-18-000055 · wf-form4_153065414745408.xml · nonDerivative · entry 1 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,523 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2017 Filed Jul 18, 2017 15:42 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantDeferred Stock Units (Fee Deferral) · Derivative | 1,638 | $12.63 | $20,679.75 |
DisclosureSEC source: 0000086115-17-000086 · wf-form4_150039254602658.xml · derivative · entry 2 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,050 Underlying: Common Stock · 1,638 shares Expires not disclosed F1 · derivative.exercise_price: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. F1 · derivative.exercise_date: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. F1 · derivative.expiration_date: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. Read SEC document |
| July 15, 2017 Filed Jul 18, 2017 15:42 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantDeferred Stock Units (Match) · Derivative | 409 | $0.00 | $0.00 |
DisclosureSEC source: 0000086115-17-000086 · wf-form4_150039254602658.xml · derivative · entry 1 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,007 Underlying: Common Stock · 409 shares Expires not disclosed F1 · derivative.exercise_price: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. F1 · derivative.exercise_date: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. F1 · derivative.expiration_date: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. Read SEC document |
| July 14, 2017 Filed Jul 18, 2017 20:40 UTC | ARMSTRONG WORLD INDUSTRIES INC AWI · Entity 3696 | GrantCommon Stock | 2,298 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-023793 · form4.xml · nonDerivative · entry 1 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,875 F1 · security: Restricted stock units granted under the 2016 Directors Stock Unit Plan, as amended, and as part of the Issuer's nonemployee Director Compensation Program. The units vest (contingent upon the Director's continued service as of such date) on the earlier of (i) the one-year anniversary of the grant; (ii) the death or total and permanent disability of the Director; or (iii) the date of any Change in Control Event (as defined in the Plan). Vested units will be acquirable by the Director, at the election of the Director: (i) at the vesting of the units at the one-year anniversary of the grant or (ii) at the time of the Director's termination of service. F2 · shares: Represents an annual grant of restricted stock units as the equity portion of the Directors retainer for Board service under the Issuer's nonemployee Director Compensation Program. The grant date fair value of the units is calculated under the Financial Accounting Standards Board's Accounting Standards Codification Topic 718 using the closing stock price of the Issuer's common shares on July 14, 2017 the first business day following the Issuer's Annual Meeting of Shareholders, which price was $45.70. F3 · balance_after: Includes vested and unvested units as well as units not yet acquirable by the Director. Under the terms of the 2008 Directors Stock Unit Plan, as amended (the "2008 Plan"), vested units under the 2008 Plan are not acquirable by the Director until (i) for those restricted stock units granted prior to June 2011, six (6) months following the termination of service on the Issuer's Board of Directors, and, (ii) for those units granted during and after June 2011, at the time of termination of service on the Issuer's Board of Directors. Under the terms of the 2016 Directors Stock Unit Plan, as amended (the "2016 Plan"), vested units under the 2016 Plan are not acquirable by the Director until, at the election of the Director: (i) the vesting of the units at the one-year anniversary of the grant or (ii) the time of the Director's termination of service. Read SEC document |
| July 01, 2017 Filed Jul 5, 2017 18:18 UTC | VONAGE HOLDINGS CORP VG · Entity 125236 | GrantCommon Stock | 4,396 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-043647 · doc4.xml · nonDerivative · entry 1 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,505 Read SEC document |
| May 31, 2017 Filed May 31, 2017 17:28 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantDeferred Stock Unit Award 2017 · Derivative | 7,406 | $0.00 | $0.00 |
DisclosureSEC source: 0000086115-17-000073 · wf-form4_149625167495087.xml · derivative · entry 1 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,406 Underlying: Common Stock · 7,406 shares Expires not disclosed F1 · derivative.exercise_price: The deferred stock units are payable in stock, on a one-for-one basis. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. F1 · derivative.exercise_date: The deferred stock units are payable in stock, on a one-for-one basis. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. F1 · derivative.expiration_date: The deferred stock units are payable in stock, on a one-for-one basis. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 19:18 UTC | PENNSYLVANIA REAL ESTATE INVESTMENT TRUST PEI · Entity 92323 | PurchaseShares of Beneficial Interest, par value $1.00 per share | 10,000 | $10.76 | $107,600.00 |
DisclosureSEC source: 0001351595-17-000014 · primary_doc.xml · nonDerivative · entry 1 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,060 Read SEC document |
| May 26, 2017 Filed May 30, 2017 17:28 UTC | VONAGE HOLDINGS CORP VG · Entity 125236 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $3.06 | $0.00 |
DisclosureSEC source: 0001209191-17-036184 · doc4.xml · derivative · entry 3 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,750 shares Expires 2017-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option, representing a right to purchase a total of 3,750 shares, vested in equal quarterly installments over a period of twelve months beginning June 1, 2007. Read SEC document |
| May 26, 2017 Filed May 30, 2017 17:28 UTC | VONAGE HOLDINGS CORP VG · Entity 125236 | Tax withholdingCommon Stock | 1,618 | $7.10 | $11,479.71 |
DisclosureSEC source: 0001209191-17-036184 · doc4.xml · nonDerivative · entry 2 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,109 Read SEC document |
| May 26, 2017 Filed May 30, 2017 17:28 UTC | VONAGE HOLDINGS CORP VG · Entity 125236 | Exercise / conversionCommon Stock | 3,750 | $3.06 | $11,475.00 |
DisclosureSEC source: 0001209191-17-036184 · doc4.xml · nonDerivative · entry 1 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,727 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2017 Filed Apr 17, 2017 16:57 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantDeferred Stock Units (Fee Deferral) · Derivative | 1,694 | $12.40 | $21,005.60 |
DisclosureSEC source: 0000086115-17-000043 · wf-form4_149244825799491.xml · derivative · entry 2 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,412 Underlying: Common Stock · 1,694 shares Expires not disclosed F1 · derivative.exercise_price: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. F1 · derivative.exercise_date: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. F1 · derivative.expiration_date: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. Read SEC document |
| April 15, 2017 Filed Apr 17, 2017 16:57 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantDeferred Stock Units (Match) · Derivative | 423 | $0.00 | $0.00 |
DisclosureSEC source: 0000086115-17-000043 · wf-form4_149244825799491.xml · derivative · entry 1 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,598 Underlying: Common Stock · 423 shares Expires not disclosed F1 · derivative.exercise_price: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. F1 · derivative.exercise_date: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. F1 · derivative.expiration_date: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. Read SEC document |
| April 01, 2017 Filed Apr 4, 2017 16:53 UTC | VONAGE HOLDINGS CORP VG · Entity 125236 | GrantCommon Stock | 4,549 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-024960 · doc4.xml · nonDerivative · entry 1 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,977 Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 18:00 UTC | VONAGE HOLDINGS CORP VG · Entity 125236 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $5.21 | $0.00 |
DisclosureSEC source: 0001209191-17-016868 · doc4.xml · derivative · entry 3 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,750 shares Expires 2017-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option, representing a right to purchase a total of 3,750 shares, vested in equal quarterly installments over a period of twelve months beginning March 1, 2007. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 18:00 UTC | VONAGE HOLDINGS CORP VG · Entity 125236 | Tax withholdingCommon Stock | 3,203 | $6.10 | $19,538.30 |
DisclosureSEC source: 0001209191-17-016868 · doc4.xml · nonDerivative · entry 2 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,428 Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 18:00 UTC | VONAGE HOLDINGS CORP VG · Entity 125236 | Exercise / conversionCommon Stock | 3,750 | $5.21 | $19,537.50 |
DisclosureSEC source: 0001209191-17-016868 · doc4.xml · nonDerivative · entry 1 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,631 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 15, 2017 Filed Jan 17, 2017 13:50 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantDeferred Stock Units (Fee Deferral) · Derivative | 1,575 | $13.34 | $21,006.56 |
DisclosureSEC source: 0000086115-17-000008 · wf-form4_148466102858054.xml · derivative · entry 2 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,718 Underlying: Common Stock · 1,575 shares Expires not disclosed F1 · derivative.exercise_price: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. F1 · derivative.exercise_date: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. F1 · derivative.expiration_date: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. Read SEC document |
| January 15, 2017 Filed Jan 17, 2017 13:50 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantDeferred Stock Units (Match) · Derivative | 394 | $0.00 | $0.00 |
DisclosureSEC source: 0000086115-17-000008 · wf-form4_148466102858054.xml · derivative · entry 1 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,175 Underlying: Common Stock · 394 shares Expires not disclosed F1 · derivative.exercise_price: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. F1 · derivative.exercise_date: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. F1 · derivative.expiration_date: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. Read SEC document |
| January 01, 2017 Filed Jan 3, 2017 17:54 UTC | VONAGE HOLDINGS CORP VG · Entity 125236 | GrantCommon Stock | 4,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-000404 · doc4.xml · nonDerivative · entry 1 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,881 Read SEC document |
| December 27, 2016 Filed Dec 28, 2016 18:51 UTC | VONAGE HOLDINGS CORP VG · Entity 125236 | GiftCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-156927 · doc4.xml · nonDerivative · entry 2 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,684 F2 · shares: Representing a gift to The John & Charlene Roberts Family Foundation, Inc., a 501(c) organization. Read SEC document |
| December 23, 2016 Filed Dec 28, 2016 18:51 UTC | VONAGE HOLDINGS CORP VG · Entity 125236 | GiftCommon Stock | 17,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-156927 · doc4.xml · nonDerivative · entry 1 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,684 F1 · shares: Represents gifting of 5,000 shares to each of John Roberts, Jr. and Alexander Roberts, and 3,500 shares to each of Diane M. Roberts and Christopher Roberts, Reporting Person's adult children. Read SEC document |
| November 29, 2016 Filed Dec 1, 2016 17:53 UTC | VONAGE HOLDINGS CORP VG · Entity 125236 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $6.51 | $0.00 |
DisclosureSEC source: 0001209191-16-152731 · doc4.xml · derivative · entry 3 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,750 shares Expires 2016-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option, representing a right to purchase a total of 3,750 shares, vested in equal quarterly installments over a period of twelve months beginning on March 1, 2007. Read SEC document |
| November 29, 2016 Filed Dec 1, 2016 17:53 UTC | VONAGE HOLDINGS CORP VG · Entity 125236 | Tax withholdingCommon Stock | 3,559 | $6.86 | $24,414.74 |
DisclosureSEC source: 0001209191-16-152731 · doc4.xml · nonDerivative · entry 2 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,684 Read SEC document |
| November 29, 2016 Filed Dec 1, 2016 17:53 UTC | VONAGE HOLDINGS CORP VG · Entity 125236 | Exercise / conversionCommon Stock | 3,750 | $6.51 | $24,412.50 |
DisclosureSEC source: 0001209191-16-152731 · doc4.xml · nonDerivative · entry 1 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,243 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 15, 2016 Filed Oct 18, 2016 12:09 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantDeferred Stock Units (Fee Deferral) · Derivative | 1,383 | $13.02 | $18,005.28 |
DisclosureSEC source: 0000086115-16-000296 · wf-form4_147679257896026.xml · derivative · entry 2 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,143 Underlying: Common Stock · 1,383 shares Expires not disclosed F1 · derivative.exercise_price: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. F1 · derivative.exercise_date: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. F1 · derivative.expiration_date: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. Read SEC document |
| October 15, 2016 Filed Oct 18, 2016 12:09 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantDeferred Stock Units (Match) · Derivative | 346 | $0.00 | $0.00 |
DisclosureSEC source: 0000086115-16-000296 · wf-form4_147679257896026.xml · derivative · entry 1 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,781 Underlying: Common Stock · 346 shares Expires not disclosed F1 · derivative.exercise_price: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. F1 · derivative.exercise_date: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. F1 · derivative.expiration_date: The deferred stock units are payable in stock, on a one-for-one basis, and are fully vested at grant. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer. Read SEC document |
| October 01, 2016 Filed Oct 4, 2016 17:50 UTC | VONAGE HOLDINGS CORP VG · Entity 125236 | GrantCommon Stock | 4,349 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-144558 · doc4.xml · nonDerivative · entry 1 ROBERTS JOHN JOSEPH · CIK 0001243108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,493 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.